213 related articles for article (PubMed ID: 12885781)
1. Molecular pathway for cancer metastasis to bone.
De S; Chen J; Narizhneva NV; Heston W; Brainard J; Sage EH; Byzova TV
J Biol Chem; 2003 Oct; 278(40):39044-50. PubMed ID: 12885781
[TBL] [Abstract][Full Text] [Related]
2. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
3. SPARC Induces E-Cadherin Repression and Enhances Cell Migration through Integrin αvβ3 and the Transcription Factor ZEB1 in Prostate Cancer Cells.
López-Moncada F; Torres MJ; Lavanderos B; Cerda O; Castellón EA; Contreras HR
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682554
[TBL] [Abstract][Full Text] [Related]
4. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
[TBL] [Abstract][Full Text] [Related]
5. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
6. Integrins in bone recognition and metastasis.
Byzova T
J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):374. PubMed ID: 15758266
[No Abstract] [Full Text] [Related]
7. Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
Ribeiro N; Costa-Pinheiro P; Henrique R; Gomez-Lazaro M; Pereira MP; Mansur AAP; Mansur HS; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Nanotechnol; 2016 Aug; 12(8):1667-78. PubMed ID: 29342345
[TBL] [Abstract][Full Text] [Related]
8. Metastatic properties of prostate cancer cells are controlled by VEGF.
Chen J; De S; Brainard J; Byzova TV
Cell Commun Adhes; 2004; 11(1):1-11. PubMed ID: 15500293
[TBL] [Abstract][Full Text] [Related]
9. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.
Zhang J; Wang P; Zhu J; Wang W; Yin J; Zhang C; Chen Z; Sun L; Wan Y; Wang X; Chen G; Liu Y
Oncol Rep; 2014 May; 31(5):2312-20. PubMed ID: 24676680
[TBL] [Abstract][Full Text] [Related]
10. A selective cyclic integrin antagonist blocks the integrin receptors alphavbeta3 and alphavbeta5 and inhibits retinal pigment epithelium cell attachment, migration and invasion.
Hoffmann S; He S; Jin M; Ehren M; Wiedemann P; Ryan SJ; Hinton DR
BMC Ophthalmol; 2005 Jun; 5():16. PubMed ID: 15987521
[TBL] [Abstract][Full Text] [Related]
11. Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds.
Dardik R; Livnat T; Seligsohn U
Thromb Haemost; 2009 Nov; 102(5):975-82. PubMed ID: 19888537
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.
McCabe NP; De S; Vasanji A; Brainard J; Byzova TV
Oncogene; 2007 Sep; 26(42):6238-43. PubMed ID: 17369840
[TBL] [Abstract][Full Text] [Related]
13. Role of secreted protein acidic in hematogenous metastasis of gastric cancer.
Mo A; Yang SW; Jiang YX; Zhao YL; Shi Y; Qian F; Hao YX; Yu PW
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4311-4321. PubMed ID: 29077165
[TBL] [Abstract][Full Text] [Related]
14. Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.
Schneider JG; Amend SR; Weilbaecher KN
Bone; 2011 Jan; 48(1):54-65. PubMed ID: 20850578
[TBL] [Abstract][Full Text] [Related]
15. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
16. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer.
Said N; Najwer I; Motamed K
Am J Pathol; 2007 Mar; 170(3):1054-63. PubMed ID: 17322388
[TBL] [Abstract][Full Text] [Related]
17. Normalization of the ovarian cancer microenvironment by SPARC.
Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.
Nemeth JA; Cher ML; Zhou Z; Mullins C; Bhagat S; Trikha M
Clin Exp Metastasis; 2003; 20(5):413-20. PubMed ID: 14524530
[TBL] [Abstract][Full Text] [Related]
19. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes.
Jiang X; Liu F; Wang Y; Gao J
J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810
[TBL] [Abstract][Full Text] [Related]
20. SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
Mateo F; Meca-Cortés O; Celià-Terrassa T; Fernández Y; Abasolo I; Sánchez-Cid L; Bermudo R; Sagasta A; Rodríguez-Carunchio L; Pons M; Cánovas V; Marín-Aguilera M; Mengual L; Alcaraz A; Schwartz S; Mellado B; Aguilera KY; Brekken R; Fernández PL; Paciucci R; Thomson TM
Mol Cancer; 2014 Oct; 13():237. PubMed ID: 25331979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]